Related Experiment Videos
Homograft and prosthetic aortic valve replacement: a comparative study
Insights
This study compared homograft and prosthetic aortic valve replacements, finding similar mortality and valve failure rates in patients with comparable risk factors. However, specific complications differed between the two valve types.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Clinical Outcomes Research
Background:
- Aortic valve replacement is a critical procedure for severe aortic valve disease.
- Both homograft (allograft) and prosthetic (mechanical/bioprosthetic) valves are utilized, each with distinct characteristics and potential complications.
- Long-term comparative data on outcomes and failure modes is essential for clinical decision-making.
Purpose of the Study:
- To compare the long-term efficacy and safety of homograft versus prosthetic aortic valve replacement.
- To identify specific complications associated with each type of valve replacement.
- To evaluate the impact of preoperative patient risk factors on mortality and valve failure.
Main Methods:
- Retrospective analysis of 103 homograft and 106 prosthetic aortic valve replacement patients (1962-1973).
- Comparison of patient demographics, preoperative conditions, procedural details, and postoperative outcomes.
- Assessment of early and late mortality, valve failure rates, and specific complication types (emboli, infection, hemorrhage, hemolysis).
Main Results:
- Combined mortality was 28% (12% operative, 8% first year, 8% late). 10% of valves required re-replacement.
- Valve-related failure and infections were more frequent with homografts; emboli, hemorrhage, and hemolysis were more common with prosthetics.
- Severe preoperative symptoms, endocarditis, and specific hemodynamic profiles (e.g., aortic regurgitation with low cardiac index) were associated with increased mortality and valve failure.
Conclusions:
- In patients stratified for equal risk, mortality and valve failure rates were comparable between homograft and prosthetic aortic valve replacement.
- The choice of valve replacement may influence the pattern of complications, with homografts showing higher rates of valve failure and infection, and prosthetics showing higher rates of thromboembolic events and hemolysis.
- Preoperative patient condition significantly impacts outcomes, underscoring the importance of risk stratification in aortic valve surgery.
Abstract:
Homograft aortic valve replacement was done in 103 patients and prosthetic aortic valve replacement in 106 between January 1962 and December 1973. Patients who received homograft and prosthetic valves were compared with respect to age, sex, preoperative functional impairment, infection, dyspnea, angina, hemodynamics, chest X-ray, electrocardiogram, associated operations, early and late mortality, and valve failure. Combined total mortality was 28% (12% operative, 8% first postoperative year, 8% late). Ten percent of valve required replacement. One year after operation, 70% of survivors were asymptomatic, 27% were improved, and 3% were unchanged or between homograft and prosthetic valve replacement. Valve-related failure and infections were more common after homograft aortic valve replacement. Emboli, hemorrhage, and hemolysis were commoner after prosthetic valve replacement. Fungal infections occurred in five homograft patients but in no patient with a prosthetic aortic valve. Severe properative symptoms or recent endocarditis was associated with greater mortality and valve failure in both the homograft and the prosthetic series. Increased mortality and failure was also seen in patients with either preoperative aortic regurgitation with high left ventricular end-diastolic pressure and low cardiac index, or aortic stenosis with cardiomegaly or roentgenographic evidence of congestive heart failure. Therefore, in two series of patients at equal risk, mortality and valve failure were similar for homograft and prosthetic aortic valve replacement.